Therefore, research into improving the understanding of the issues related to NSCLC with MET fusion, such as highly sensitive and specific detection methods for MET fusion mutations; the immune feature of tumor microenvironment; and the response to chemotherapy, targeted therapy, and immunotherapy is cardinal. Here, MET is linked to non-small cell lung carcinoma.